Sara Nannizzi

1.4k total citations
21 papers, 1.2k citations indexed

About

Sara Nannizzi is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sara Nannizzi has authored 21 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sara Nannizzi's work include Pancreatic and Hepatic Oncology Research (9 papers), Cancer therapeutics and mechanisms (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Sara Nannizzi is often cited by papers focused on Pancreatic and Hepatic Oncology Research (9 papers), Cancer therapeutics and mechanisms (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Sara Nannizzi collaborates with scholars based in Italy, United States and Netherlands. Sara Nannizzi's co-authors include Romano Danesi, Elisa Giovannetti, Mario Del Tacca, Valentina Mey, S Ricciardi, Giuseppe Pasqualetti, Godefridus J. Peters, Cinzia Orlandini, Ugo Boggi and Franco Mosca and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Sara Nannizzi

20 papers receiving 1.1k citations

Peers

Countries citing papers authored by Sara Nannizzi

Since Specialization

Citations

This map shows the geographic impact of Sara Nannizzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Nannizzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Nannizzi more than expected).

Fields of papers citing papers by Sara Nannizzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Nannizzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Nannizzi. The network helps show where Sara Nannizzi may publish in the future.

Co-authorship network of co-authors of Sara Nannizzi

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Nannizzi. A scholar is included among the top collaborators of Sara Nannizzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Nannizzi. Sara Nannizzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Incidence and Recurrence of Urinary Tract Infections Caused by Uropathogenic Escherichia coli: A Retrospective Cohort Study 2024 ·Research and Reports in Urology ·Eva Raphael, (unknown), (unknown), Sara Nannizzi, (unknown), (unknown), Yuan Hu, (unknown), Johannes Schmidt	0
2	Synergistic Cytotoxicity and Molecular Interaction on Drug Targets of Sorafenib and Gemcitabine in Human Pancreas Cancer Cells 2010 ·Chemotherapy ·S Ricciardi, Valentina Mey, Sara Nannizzi, Giuseppe Pasqualetti, Francesco Crea, Mario Del Tacca, Romano Danesi	16
3	Epigenetic mechanisms of irinotecan sensitivity in colorectal cancer cell lines 2009 ·Molecular Cancer Therapeutics ·Francesco Crea, Elisa Giovannetti, Filippo Cortesi, Valentina Mey, Sara Nannizzi, (unknown), S Ricciardi, Mario Del Tacca, Godefridus J. Peters, Romano Danesi	34
4	Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer 2009 ·Cancer Chemotherapy and Pharmacology ·Gabriella Ferrandina, Valentina Mey, Sara Nannizzi, S Ricciardi, Marco Petrillo, Cristiano Ferlini, Romano Danesi, Giovanni Scambia, Mario Del Tacca	45
5	Cellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines 2009 ·Cancer Chemotherapy and Pharmacology ·Sara Nannizzi, Gareth J. Veal, Elisa Giovannetti, Valentina Mey, S Ricciardi, Christopher J. Ottley, Mario Del Tacca, Romano Danesi	17
6	Single nucleotide polymorphisms and clinical outcome in patients with biliary tract carcinoma treated with epirubicin, cisplatin and capecitabine. 2009 ·PubMed ·Paola Pacetti, Elisa Giovannetti, Andrea Mambrini, Sara Nannizzi, (unknown), (unknown), (unknown), Mario Del Tacca, Romano Danesi, Maurizio Cantore	8
7	Correlation Between Cytidine Deaminase Genotype and Gemcitabine Deamination in Blood Samples 2008 ·Nucleosides Nucleotides & Nucleic Acids ·Elisa Giovannetti, (unknown), Enrico Vasile, Carmelo Tibaldi, Sara Nannizzi, Serena Ricciardi, Alfredo Falcone, Romano Danesi, Godefridus J. Peters	53
8	Molecular Mechanisms Underlying the Synergistic Interaction of Erlotinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, with the Multitargeted Antifolate Pemetrexed in Non-Small-Cell Lung Cancer Cells 2008 ·Molecular Pharmacology ·Elisa Giovannetti, Clara Lemos, Christina Tekle, Kees Smid, Sara Nannizzi, José Antonio Rodríguez, S Ricciardi, Romano Danesi, Giuseppe Giaccone, Godefridus J. Peters	130
9	Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma 2008 ·Laboratory Investigation ·Niccola Funel, Elisa Giovannetti, Marco Del Chiaro, Valentina Mey, Luca Emanuele Pollina, Sara Nannizzi, Ugo Boggi, S Ricciardi, Mario Del Tacca, Generoso Bevilacqua, Franco Mosca, Romano Danesi, Daniela Campani	27
10	A case of drug resistant clear cell ovarian cancer showing responsiveness to gemcitabine at first administration and at re-challenge 2007 ·Cancer Chemotherapy and Pharmacology ·Gabriella Ferrandina, Francesco Legge, Valentina Mey, Sara Nannizzi, S Ricciardi, Marco Petrillo, Giacomo Corrado, Giovanni Scambia	10
11	Cytotoxic activity of gemcitabine and correlation with expression profile of drug-related genes in human lymphoid cells 2007 ·Pharmacological Research ·Elisa Giovannetti, Valentina Mey, (unknown), Sara Nannizzi, (unknown), (unknown), S Ricciardi, Mario Del Tacca, Romano Danesi	26
12	Correlation of cytidine deaminase (CDA), xeroderma pigmentosum group D (XPD) and excision repair cross-complementing 1 (ERCC1) genes single nucleotide polymorphisms (SNPS) with response and survival in gemcitabine/cisplatin treated advanced non-small-cell lung cancer (NSCLC) patients 2007 ·CINECA IRIS Institutial research information system (University of Pisa) ·Carmelo Tibaldi, Elisa Giovannetti, Enrico Vasile, Valentina Mey, Sara Nannizzi, (unknown), Cinzia Orlandini, Mario Del Tacca, Alfredo Falcone, Romano Danesi	8
13	In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients 2006 ·British Journal of Cancer ·Valentina Mey, Elisa Giovannetti, Filippo de Braud, Sara Nannizzi, Giuseppe Curigliano, Fabrizio Verweij, Ottavio De Cobelli, Salvatore Pece, Mario Del Tacca, Romano Danesi	42
14	In vitro studies on gemcitabine combinations with other antiblastics 2006 ·Annals of Oncology ·Elisa Giovannetti, Romano Danesi, Valentina Mey, Sara Nannizzi, Giuseppe Pasqualetti, Mario Del Tacca	12
15	Synergistic Antitumor Activity of ZD6474, An Inhibitor of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor Signaling, with Gemcitabine and Ionizing Radiation against Pancreatic Cancer 2006 ·Clinical Cancer Research ·Cataldo Bianco, Elisa Giovannetti, Fortunato Ciardiello, Valentina Mey, Sara Nannizzi, Giampaolo Tortora, Teresa Troiani, Francesco Pasqualetti, Gail Eckhardt, (unknown), S Ricciardi, Mario Del Tacca, David Raben, L. Cionini, Romano Danesi	46
16	Transcription Analysis of Human Equilibrative Nucleoside Transporter-1 Predicts Survival in Pancreas Cancer Patients Treated with Gemcitabine 2006 ·Cancer Research ·Elisa Giovannetti, Mario Del Tacca, Valentina Mey, Niccola Funel, Sara Nannizzi, Sergio Ricci, Cinzia Orlandini, Ugo Boggi, Daniela Campani, Marco Del Chiaro, Mauro Iannopollo, Generoso Bevilacqua, Franco Mosca, Romano Danesi	278
17	Analysis of single nucleotide polymorphisms (SNPs) of cytidine deaminase (CDA) and xeroderma pigmentosum group D (XPD) genes for the prediction of clinical response to gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC) patients 2006 ·Journal of Clinical Oncology ·Enrico Vasile, Elisa Giovannetti, Carmelo Tibaldi, Valentina Mey, Sara Nannizzi, Lorenza Landi, I. Stasi, Romano Danesi, Mario Del Tacca, Alfredo Falcone	3
18	Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer 2006 ·Molecular Cancer Therapeutics ·Elisa Giovannetti, Valentina Mey, Sara Nannizzi, Giuseppe Pasqualetti, Mario Del Tacca, Romano Danesi	76
19	Cellular and Pharmacogenetics Foundation of Synergistic Interaction of Pemetrexed and Gemcitabine in Human Non–Small-Cell Lung Cancer Cells 2005 ·Molecular Pharmacology ·Elisa Giovannetti, Valentina Mey, Sara Nannizzi, Giuseppe Pasqualetti, Luca Marini, Mario Del Tacca, Romano Danesi	154
20	Near-field optical microscopy of polymer-based films with dispersed terthiophene chromophores for polarizer applications 2004 ·Nanotechnology ·Antonio Ambrosio, Michele Alderighi, M. Labardi, L. Pardi, F. Fuso, M. Allegrini, Sara Nannizzi, Andrea Pucci, Giacomo Ruggeri	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact